Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
251,80 € ↑6,70 (2,73%)
2026-06-03
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in DUL / Alnylam Pharmaceuticals, Inc.

On November 12, 2025 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 1,134 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 21,500 of underlying shares valued at $8,549,475 USD and put options representing 5,000 of underlying shares valued at $1,988,250 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-12 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -1,134 -100.00 0 -100.00
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,134 -5,068 -81.72 370 -77.96 0.0008
2025-05-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,202 6,202 1,675 0.0049
2023-02-09 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -1,999 -100.00 0 -100.00
2022-11-09 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,999 -60,219 -96.79 400 -95.59 0.0008
2022-08-11 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 62,218 38,222 159.28 9,075 131.62 0.0142
2022-05-12 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 23,996 2,854 13.50 3,918 9.29 0.0039
2022-02-11 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 21,142 9,356 79.38 3,585 61.12 0.0029
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,786 -796 -6.33 2,225 4.31 0.0024
2021-08-10 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 12,582 -25,416 -66.89 2,133 -60.24 0.0026
2021-05-12 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 37,998 37,998 5,365 0.0079
2020-11-12 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -10,700 -100.00 0 -100.00
2020-08-13 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 10,700 10,700 1,585 0.0073
2019-05-14 2019-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -1,990 -100.00 0 -100.00
2019-02-05 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,990 -27,794 -93.32 145 -94.44 0.0013
2018-11-08 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 29,784 15,921 114.85 2,607 90.99 0.0206
2018-08-13 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 13,863 13,863 1,365 0.0117
2018-05-16 2018-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -8,587 -100.00 0 -100.00
2018-02-09 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,587 -60,156 -87.51 1,091 -86.49 0.0077
2017-11-15 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 68,743 41,601 153.27 8,077 273.07 0.0733
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 27,142 -9,747 -26.42 2,165 14.49 0.0225
2017-05-10 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 36,889 14,358 63.73 1,891 124.05 0.0220
2017-02-15 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 22,531 11,165 98.23 844 9.61 0.0082
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,366 11,366 0.00 770 0.0084
2016-05-12 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -275 -100.00 0 -100.00
2016-02-11 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 275 -15,700 -98.28 26 -97.98 0.0003
2015-11-20 2015-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 15,975 8,257 106.98 1,284 38.81 0.0178
2015-11-06 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 15,975 1,284
2015-08-11 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,718 4,837 167.89 925 207.31 0.0129
2015-05-14 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,881 2,881 0.00 301 0.0047
2015-02-11 2014-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -13,743 -100.00 0 -100.00
2014-10-31 2014-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 13,743 6,178 81.67 1,073 124.48 0.0165
2014-08-12 2014-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,565 -1,642 -17.83 478 -22.65 0.0074
2014-05-07 2014-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 9,207 8,772 2,016.55 618 2,107.14 0.0104
2014-01-31 2013-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 435 -2,839 -86.71 28 -72.55 0.0004
2013-08-02 2013-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,274 3,274 102 0.0025
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 21,500 22.16 8,549 6.53 n/a n/a n/a
2025-11-12 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 17,600 13.55 8,026 58.79 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 15,500 -45.42 5,054 -34.09 n/a n/a n/a
2025-05-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 28,400 32.09 7,669 51.57 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ALNYLAM PHARMACEUTICALS COM Call 21,500 -44.16 5,059 -52.22 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 21,500 5,059 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 38,500 57.14 10,589 77.86 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 24,500 -24.62 5,954 22.57 n/a n/a n/a
2024-05-10 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 32,500 -46.28 4,857 -58.06 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 60,500 -12.57 11,580 -5.51 n/a n/a n/a
2023-11-09 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 69,200 73.43 12,255 61.72 n/a n/a n/a
2023-08-09 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 39,900 -3.39 7,579 -8.40 n/a n/a n/a
2023-05-12 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 41,300 -3.05 8,273 -18.28 n/a n/a n/a
2023-02-09 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 42,600 42.00 10,124 68.58 n/a n/a n/a
2022-11-09 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 30,000 -66.52 6,005 -54.05 n/a n/a n/a
2022-08-11 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 89,600 343.56 13,068 296.24 n/a n/a n/a
2022-05-12 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 20,200 -54.40 3,298 -56.10 n/a n/a n/a
2022-02-11 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 44,300 9.65 7,512 -1.52 n/a n/a n/a
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 40,400 94.23 7,628 116.34 n/a n/a n/a
2021-08-10 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 20,800 230.16 3,526 296.18 n/a n/a n/a
2021-05-12 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 6,300 -85.35 890 -84.08 n/a n/a n/a
2021-02-10 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 43,000 -4.66 5,589 -14.89 n/a n/a n/a
2020-11-12 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 45,100 106.88 6,567 103.38 n/a n/a n/a
2020-08-13 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 21,800 -63.67 3,229 -50.56 n/a n/a n/a
2020-05-13 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 60,000 -23.27 6,531 -27.48 n/a n/a n/a
2020-02-10 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 78,200 -20.85 9,006 13.34 n/a n/a n/a
2019-11-12 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 98,800 381.95 7,946 434.36 n/a n/a n/a
2019-08-09 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 20,500 -49.63 1,487 -60.90 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Call 40,700 -62.17 3,803 -51.52 n/a n/a n/a
2019-05-13 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 40,700 3,803 n/a n/a n/a
2019-02-05 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 107,600 -3.67 7,845 -19.75 n/a n/a n/a
2018-11-08 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 111,700 42.84 9,776 26.93 n/a n/a n/a
2018-08-13 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 78,200 362.72 7,702 282.61 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Call 16,900 -33.20 2,013 -37.37 n/a n/a n/a
2018-05-10 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 16,900 2,013 n/a n/a n/a
2018-02-09 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 25,300 -81.94 3,214 -80.47 n/a n/a n/a
2017-11-15 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 140,100 211.33 16,460 358.62 n/a n/a n/a
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 45,000 31.58 3,589 104.73 n/a n/a n/a
2017-05-10 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 34,200 -10.00 1,753 23.19 n/a n/a n/a
2017-02-15 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 38,000 -46.48 1,423 -70.43 n/a n/a n/a
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 71,000 42.00 4,812 73.41 n/a n/a n/a
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 50,000 20.77 2,775 6.77 n/a n/a n/a
2016-05-12 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 41,400 231.20 2,599 120.82 n/a n/a n/a
2016-02-11 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 12,500 27.55 1,177 49.37 n/a n/a n/a
2015-11-20 2015-09-30 13F/A ALNYLAM PHARMACEUTICALS COM Call 9,800 68.97 788 13.38 n/a n/a n/a
2015-11-06 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 9,800 788 n/a n/a n/a
2015-08-11 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 5,800 -71.00 695 -66.71 n/a n/a n/a
2015-05-14 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 20,000 -30.80 2,088 -25.51 n/a n/a n/a
2015-02-11 2014-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 28,900 45.23 2,803 80.37 n/a n/a n/a
2014-10-31 2014-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 19,900 89.52 1,554 134.39 n/a n/a n/a
2014-08-12 2014-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 10,500 854.55 663 795.95 n/a n/a n/a
2014-05-07 2014-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 1,100 -71.05 74 -69.67 n/a n/a n/a
2014-01-31 2013-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 3,800 -76.25 244 -76.17 n/a n/a n/a
2013-11-15 2013-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 16,000 -61.45 1,024 -20.44 n/a n/a n/a
2013-08-02 2013-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 41,500 1,287 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 5,000 163.16 1,988 129.56 n/a n/a n/a
2025-11-12 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 1,900 -47.22 866 -26.17 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 3,600 -81.73 1,174 -77.95 n/a n/a n/a
2025-05-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 19,700 418.42 5,319 494.97 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ALNYLAM PHARMACEUTICALS COM Put 3,800 -47.95 894 -55.46 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 3,800 894 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 7,300 97.30 2,008 123.25 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 3,700 -30.19 899 13.51 n/a n/a n/a
2024-05-10 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 5,300 23.26 792 -3.77 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 4,300 -82.80 823 -81.41 n/a n/a n/a
2023-11-09 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 25,000 121.24 4,428 106.29 n/a n/a n/a
2023-08-09 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 11,300 -0.88 2,146 -6.00 n/a n/a n/a
2023-05-12 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 11,400 -86.81 2,284 -88.88 n/a n/a n/a
2023-02-09 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 86,400 -20.66 20,533 -5.80 n/a n/a n/a
2022-11-09 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 108,900 -31.98 21,797 -6.65 n/a n/a n/a
2022-08-11 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 160,100 91.74 23,351 71.26 n/a n/a n/a
2022-05-12 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 83,500 32.75 13,635 27.82 n/a n/a n/a
2022-02-11 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 62,900 -25.39 10,667 -32.98 n/a n/a n/a
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 84,300 -19.87 15,917 -10.75 n/a n/a n/a
2021-08-10 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 105,200 1,231.65 17,834 1,499.46 n/a n/a n/a
2021-05-12 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 7,900 -71.48 1,115 -69.03 n/a n/a n/a
2021-02-10 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 27,700 502.17 3,600 437.31 n/a n/a n/a
2020-11-12 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 4,600 -80.00 670 -80.33 n/a n/a n/a
2020-08-13 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 23,000 -45.24 3,407 -25.48 n/a n/a n/a
2020-05-13 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 42,000 -72.76 4,572 -74.26 n/a n/a n/a
2020-02-10 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 154,200 28.82 17,759 84.49 n/a n/a n/a
2019-11-12 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 119,700 2,342.86 9,626 2,603.93 n/a n/a n/a
2019-08-09 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 4,900 -25.76 356 -42.30 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Put 6,600 -56.29 617 -43.96 n/a n/a n/a
2019-05-13 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 6,600 617 n/a n/a n/a
2019-02-05 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 15,100 -80.24 1,101 -83.54 n/a n/a n/a
2018-11-08 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 76,400 225.11 6,687 188.86 n/a n/a n/a
2018-08-13 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 23,500 -67.85 2,315 -73.41 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Put 73,100 29.15 8,706 21.07 n/a n/a n/a
2018-05-10 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 73,100 8,706 n/a n/a n/a
2018-02-09 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 56,600 -70.57 7,191 -68.17 n/a n/a n/a
2017-11-15 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 192,300 99.69 22,593 194.14 n/a n/a n/a
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 96,300 76.70 7,681 175.01 n/a n/a n/a
2017-05-10 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 54,500 0.18 2,793 37.11 n/a n/a n/a
2017-02-15 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 54,400 -25.58 2,037 -58.89 n/a n/a n/a
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 73,100 21.83 4,955 48.84 n/a n/a n/a
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 60,000 130.77 3,329 103.98 n/a n/a n/a
2016-05-12 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 26,000 79.31 1,632 19.56 n/a n/a n/a
2016-02-11 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 14,500 -57.60 1,365 -50.33 n/a n/a n/a
2015-11-20 2015-09-30 13F/A ALNYLAM PHARMACEUTICALS COM Put 34,200 21.28 2,748 -18.70 n/a n/a n/a
2015-11-06 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 34,200 2,748 n/a n/a n/a
2015-08-11 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 28,200 -37.19 3,380 -27.90 n/a n/a n/a
2015-05-14 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 44,900 55.36 4,688 67.25 n/a n/a n/a
2015-02-11 2014-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 28,900 588.10 2,803 754.57 n/a n/a n/a
2014-10-31 2014-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 4,200 -70.00 328 -62.90 n/a n/a n/a
2014-08-12 2014-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 14,000 -28.93 884 -33.18 n/a n/a n/a
2014-05-07 2014-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 19,700 239.66 1,323 254.69 n/a n/a n/a
2014-01-31 2013-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 5,800 -49.57 373 -49.32 n/a n/a n/a
2013-11-15 2013-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 11,500 -26.75 736 51.13 n/a n/a n/a
2013-08-02 2013-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 15,700 487 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.